CME Group Inc (NASDAQ: CME) has seen a decline in its stock price by -2.89 in relation to its previous close of 290.71. However, the company has experienced a -0.72% decline in its stock price over the last five trading sessions. seekingalpha.com reported 2025-06-03 that CME Group remains a buy, despite a premium valuation, thanks to strong cash flow, market dominance, and a resilient business model. The company’s recurring revenue, high margins, and growth across product lines justify its higher multiple and support 20% upside potential. Risks include regulatory changes, tech migration challenges, legal headwinds, and potential market slowdowns, but these are manageable for long-term investors.
Is It Worth Investing in CME Group Inc (NASDAQ: CME) Right Now?
CME Group Inc (NASDAQ: CME) has a price-to-earnings ratio that is above its average at 28.38x. The stock has a 36-month beta value of 0.47. Opinions on the stock are mixed, with 4 analysts rating it as a “buy,” 3 as “overweight,” 7 as “hold,” and 0 as “sell.”
The public float for CME is 359.23M, and at present, short sellers hold a 1.32% of that float. On June 04, 2025, the average trading volume of CME was 2.69M shares.
CME’s Market Performance
The stock of CME Group Inc (CME) has seen a -0.72% decrease in the past week, with a 0.66% rise in the past month, and a 12.04% gain in the past quarter. The volatility ratio for the week is 1.80%, and the volatility levels for the past 30 days are at 1.63% for CME. The simple moving average for the last 20 days is 0.62% for CME stock, with a simple moving average of 18.00% for the last 200 days.
Analysts’ Opinion of CME
Many brokerage firms have already submitted their reports for CME stocks, with Morgan Stanley repeating the rating for CME by listing it as a “Overweight.” The predicted price for CME in the upcoming period, according to Morgan Stanley is $301 based on the research report published on April 08, 2025 of the current year 2025.
Raymond James, on the other hand, stated in their research note that they expect to see CME reach a price target of $287. The rating they have provided for CME stocks is “Outperform” according to the report published on March 10th, 2025.
Citigroup gave a rating of “Neutral” to CME, setting the target price at $250 in the report published on January 06th of the current year.
CME Trading at 4.23% from the 50-Day Moving Average
After a stumble in the market that brought CME to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -2.92% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CME starting from Kaye Daniel G, who sale 500 shares at the price of $282.42 back on May 22 ’25. After this action, Kaye Daniel G now owns 3,668 shares of CME Group Inc, valued at $141,210 using the latest closing price.
Kaye Daniel G, the Director of CME Group Inc, proposed sale 500 shares at $282.50 during a trade that took place back on May 22 ’25, which means that Kaye Daniel G is holding shares at $141,250 based on the most recent closing price.
Stock Fundamentals for CME
Current profitability levels for the company are sitting at:
- 0.65 for the present operating margin
- 0.86 for the gross margin
The net margin for CME Group Inc stands at 0.57. The total capital return value is set at 0.11. Equity return is now at value 13.40, with 2.50 for asset returns.
Based on CME Group Inc (CME), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at 1.14. The debt to equity ratio resting at 0.13. The interest coverage ratio of the stock is 25.08.
Currently, EBITDA for the company is 4.61 billion with net debt to EBITDA at 0.4. When we switch over and look at the enterprise to sales, we see a ratio of 16.51. The receivables turnover for the company is 8.16for trailing twelve months and the total asset turnover is 0.04. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.02.
Conclusion
To sum up, CME Group Inc (CME) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
